Investigational drug · Phase 2
AV078
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Tuberous Sclerosis Complex, Epilepsy.
Phase 2Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
2
Any phase or sponsor naming "AV078"
First trial start
2026
Sep 1, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "AV078", any sponsor or status.
Conditions studied
As listed on its trial records.
- Tuberous Sclerosis Complex
- Epilepsy
Approved drugs for the same conditions: Epilepsy and seizures · Neurology
Largest trials
Live from ClinicalTrials.gov: studies naming "AV078" as an intervention, largest first.
Aeovian Pharmaceuticals, Inc.Industry
NCT06205381 · 89 participants · Start Jan 31, 2024 · Primary completion Feb 8, 2025
Drug: AV078; Placebo and 3 more · For: Healthy Participants
Sites: Herston, Australia; Melbourne, Australia
- Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Complex (TSC) Refractory Epilepsy (RESTOR-1)Not yet recruiting
Aeovian Pharmaceuticals, Inc.Industry
NCT07680322 · 42 participants (planned) · Start Sep 1, 2026 · Primary completion Sep 1, 2027
Drug: AV078; Placebo · For: Tuberous Sclerosis Complex; Epilepsy
Sites: London, Canada
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Tuberous Sclerosis Complex
- BasimglurantNOE-101Phase 32 trials
Noema Pharma AG · Trigeminal Neuralgia, Tuberous Sclerosis Complex
- RadiprodilPhase 32 trials
GRIN Therapeutics, Inc. · GRIN-related Neurodevelopmental Disorder, Tuberous Sclerosis Complex, Focal Cortical Dysplasia
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.